The Role of Ampligen in Strategic Therapeutic Intervention (STI) of HAART

Clinical trial NCT00035893 · COMPLETED

Trial details

NCT number: NCT00035893
Sponsor: AIM ImmunoTech Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

HIV Seropositivity HIV Infection

Start date: 2001-05-01
Primary completion: 2006-08-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.